Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-02 Option Award |
2025-01-06 5:51 pm |
N/A 2034-12-31 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
131,900 | $0 | 131,900 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 4:37 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
131,900 | $0 | 131,900 (Direct) |
View |
2023-01-03 Option Award |
2023-01-09 9:36 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
86,200 | $0 | 86,200 (Direct) |
View |
2022-01-06 Option Award |
2022-01-18 6:30 pm |
N/A 2032-01-05 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
51,088 | $0 | 51,088 (Direct) |
View |
2020-08-03 Option Award |
2021-05-04 4:30 pm |
N/A 2030-08-02 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
312,767 | $0 | 312,767 (Direct) |
View |
Ownership |
2021-04-29 4:54 pm |
N/A 2030-08-02 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
0 | $0 | 264,312 (Direct) |
View |